Abstract 1769: LY4170156, an antibody-drug conjugate targeting folate receptor alpha, exhibits enhanced antitumor activity in combination with standard-of-care therapies in preclinical ovarian cancer models
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Zhaohai Lu, Chun Ping Yu, Jack A. Dempsey, Wei Guo Xu, Lisa Kays, Bonita D. Jones, Andrew Capen, Xueqian Gong
Institutions: Eli Lilly (United States), Lilly (China)
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148751617
Cites:
Cited by:
Related to: